134 related articles for article (PubMed ID: 2412927)
1. Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.
Sawabu N; Wakabayashi T; Ozaki K; Toya D; Yoneshima M; Kidani H; Hattori N; Ishii M
Gastroenterol Jpn; 1985 Jun; 20(3):209-15. PubMed ID: 2412927
[TBL] [Abstract][Full Text] [Related]
2. [Tumor markers of hepatocellular carcinoma with special reference to diagnostic efficacy of combination of these markers and relation to its stages].
Sawabu N; Wakabayashi T; Ozaki K; Toya D; Yoneshima M
Gan No Rinsho; 1983 May; 29(6):672-7. PubMed ID: 6192267
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
Li J; Tao H; Zhang E; Huang Z
Cancer Med; 2021 Jul; 10(14):4844-4854. PubMed ID: 34145988
[TBL] [Abstract][Full Text] [Related]
4. Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Bell H
Scand J Gastroenterol; 1982 Oct; 17(7):897-903. PubMed ID: 6186010
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.
Carr BI; Guerra V; Pancoska P
Oncology; 2012; 83(6):339-45. PubMed ID: 23006937
[TBL] [Abstract][Full Text] [Related]
7. Low alpha-fetoprotein HCC and the role of GGTP.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
[TBL] [Abstract][Full Text] [Related]
8. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Balasegaram M; Timor J; Thambyrajah V
Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
[TBL] [Abstract][Full Text] [Related]
9. Serum tumor markers for detection of hepatocellular carcinoma.
Zhou L; Liu J; Luo F
World J Gastroenterol; 2006 Feb; 12(8):1175-81. PubMed ID: 16534867
[TBL] [Abstract][Full Text] [Related]
10. Novel gamma-GTP isoenzyme as diagnostic tool for hepatocellular carcinoma.
Sawabu N; Nakagen M; Ozaki K; Wakabayashi T; Toya D; Hattori N; Ishii M
Ann Acad Med Singap; 1980 Apr; 9(2):206-9. PubMed ID: 6158905
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of serum "hepatoma-specific" gamma-glutamyl transferase and alkaline phosphatase].
Xu KC
Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):247-9. PubMed ID: 2417791
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of tumour marker proteins in the diagnosis of primary hepatocellular carcinoma.
Oon CJ; Yo SL; Chio LF; Chua D; Tan YO
Ann Acad Med Singap; 1980 Apr; 9(2):228-33. PubMed ID: 6158907
[TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Xu K; Meng XY; Wu JW; Shen B; Shi YC; Wei Q
Am J Gastroenterol; 1992 Aug; 87(8):991-5. PubMed ID: 1353662
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
19. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]